Navigation Links
International Isotopes Inc. Names James Mayer as Chief Operating Officer

IDAHO FALLS, Idaho, Jan. 14 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) is pleased to announce the appointment of James Mayer as Chief Operating Officer (COO).

James Mayer joined International Isotopes as Chief Operating Officer on January 11, 2008. Mr. Mayer received his Bachelor of Science in Nuclear Engineering from Texas A & M University and a Masters of Business Administration from the University of Nebraska at Lincoln. He has over 25 years of management experience in the U.S. Navy as well as civilian corporations and he has previously served as Facility Manager, Senior Project Engineer, and Production Manager at a Fortune 500 corporation.

Steve T. Laflin, International Isotopes Inc. President and Chief Executive Officer said, "The Company has not previously had a COO position. However, our rapidly growing manufacturing operations and increasing corporate demands created by additional business opportunities for the Company dictate the need for a dedicated COO. Mr. Mayer has in-depth familiarity with the nuclear industry as well as the commercial sector. He brings with him solid business, management, and operational skills and broad-based experience in manufacturing. He is an outstanding fit to our team and I am certain he will become a valuable asset to the Company as we strive to improve our production efficiencies, reduce operating costs, and incorporate new product lines into the Idaho operations."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

For more information, visit our website:

International Isotopes Inc. Safe Harbor Statement

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change. Actual results may differ materially from the forward-looking statements. Many factors could cause actual results to differ materially from the forward-looking statements. Readers are directed to read the risk factors detailed from time to time in our filings with the Securities and Exchange Commission, including our annual report on Form 10-KSB for the year ending December 31, 2006. The Company does not intend to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For More Information, Contact:

Steve Laflin, President and CEO

(208) 524-5300

SOURCE International Isotopes Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International brain aging expert challenges the existence of Alzheimers as a disease
2. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
3. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
4. International Sports Sciences Associations Ten Best Resolutions for Better Health in 2008
5. Joint Commission International Achieves Accreditation from ISQua
6. International Development Expert to Lead the Pan American Health and Education Foundation
7. Natural Nutrition Launches Long Life Cocktail with International Television Ad Campaign
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. NEWSWEEK: International Editions: Highlights and Exclusives, Dec. 31, 2007- Jan. 7, 2008
10. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: